China will strengthen regulation and supervision of vaccines to ensure their safety, the country’s top drug regulator said Monday.
Chinese-made vaccines are generally safe, and China is currently working to establish a vaccine management mechanism with long-term effects, Jiao Hong, head of the National Medical Products Administration, said at a press conference.
The lawmakers have finished their first reading of a draft law on vaccine management, and solicited public opinions, she said.
Vaccine-producing companies should build a sound quality management system and product safety tracing and risk reporting mechanisms.
Provincial drug regulators should enhance on-site checks on vaccine producers while the national administration will strengthen random checks, she said.
China will develop and train national and provincial professional inspectors to enhance supervision capabilities, she added.
Source(s): Xinhua News Agency/CGTN